Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren P Mason

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Neuro-Oncology|August 5, 2008
A novel tool to analyze MRI recurrence patterns in glioblastomaWolfgang Wick, Roger Stupp, Anna-Carina Beule, et al.
Journal of Neuro-Oncology|January 19, 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Journal of Neuro-Oncology|February 9, 2026
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Neuro-Oncology Advances|May 12, 2025
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectivesChristianne V Mojica, Thiago Pimentel Muniz, Xin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
Journal of Neuro-Oncology|July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiationAkifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
Neuro-Oncology Advances|February 5, 2024
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastomaMatthijs van der Meulen, Ronald C Ramos, Mathew R Voisin, et al.
Journal of Neuro-Oncology|July 8, 2020
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patientsSeth A Climans, Alba A Brandes, J Gregory Cairncross, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Neuro-Oncology|August 5, 2008
A novel tool to analyze MRI recurrence patterns in glioblastomaWolfgang Wick, Roger Stupp, Anna-Carina Beule, et al.
Journal of Neuro-Oncology|January 19, 2026
Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Journal of Neuro-Oncology|February 9, 2026
Correction to: Nomograms for predicting survival of elderly patients with newly diagnosed glioblastoma: a secondary analysis of the CCTG CE.6 trialFabio Y Moraes, Jonah Isen, James Perry, et al.
Neuro-Oncology Advances|May 12, 2025
Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectivesChristianne V Mojica, Thiago Pimentel Muniz, Xin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trialFrancesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
Journal of Neuro-Oncology|July 17, 2022
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiationAkifumi Hagiwara, Jacob Schlossman, Soroush Shabani, et al.
Neuro-Oncology Advances|February 5, 2024
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastomaMatthijs van der Meulen, Ronald C Ramos, Mathew R Voisin, et al.
Journal of Neuro-Oncology|July 8, 2020
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patientsSeth A Climans, Alba A Brandes, J Gregory Cairncross, et al.
Pageof 12